Ucello Biotechnology
PrivateLast Round
Series A
Extension
Jun 2, 2023
Est. Valuation
$105.8M
Total Funding Raised
$77.74M
Company Overview
Ucello Biotechnology operates in Healthcare & Life Sciences and is based in Chengdu. Its latest recorded funding round was a Series A Extension round in June 2023.
Ucello Biotechnology is a biotechnology company that specializes in the research, development, and commercialization of allogeneic universal CAR-T cell therapeutic drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ucello Biotechnology Comparables
Compare Ucello Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qihan Biotech | 86% | |
| BRL Medicine Inc. | 81% | |
| Bioheng Therapeutics | 80% |
For institutional investors. Book with your work email.
Ucello Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 2, 2023 | ||||
| Series C | Aug 11, 2022 | ||||
| Series A | Feb 10, 2022 | ||||
| Series B | Mar 30, 2021 | ||||
| Series A | Oct 18, 2018 | ||||
Angel | Mar 1, 2016 |
For institutional investors. Book with your work email.
Ucello Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Co-Win Ventures | Series A Extension, Series A, Angel |
| Northern Light Venture Capital | Series A, Angel |
| Shenzhen Guozhong Venture Capital Management | Series A Extension |
| MPC | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2023
Raised $21M from Co-Win Ventures, MPC, and Shenzhen Guozhong.
- Feb 10, 2022
$25M round led by MPC.
For institutional investors. Book with your work email.
Ucello Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ucello Biotechnology's valuation, stock price, and market status.
Is Ucello Biotechnology a public or private company?
Ucello Biotechnology is a private company.
What is the current stock price of Ucello Biotechnology?
Ucello Biotechnology is a private company, so its shares have no public market price. Caplight tracks Ucello Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ucello Biotechnology worth (valuation)?
Ucello Biotechnology's valuation is estimated at $105.8M based on funding round data.
Can I buy Ucello Biotechnology stock?
Ucello Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ucello Biotechnology's last funding round?
Ucello Biotechnology's most recent funding round was Series A Extension on June 2, 2023.
Who are the main investors in Ucello Biotechnology?
Key investors in Ucello Biotechnology include MPC.
Will Ucello Biotechnology IPO soon?
No public IPO plans have been announced for Ucello Biotechnology.
How can I track Ucello Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Ucello Biotechnology's shares on secondary markets.